These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6132578)

  • 1. The manifold actions of neurotensin: a first synthesis.
    Prange AJ; Nemeroff CB
    Ann N Y Acad Sci; 1982; 400():368-75. PubMed ID: 6132578
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of neurotensin with brain dopamine systems.
    Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
    Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroanatomical sites of action of neurotensin.
    Kalivas PW; Nemeroff CB; Prange AJ
    Ann N Y Acad Sci; 1982; 400():307-18. PubMed ID: 6963113
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
    Kalivas PW; Richardson-Carlson R; Duffy P
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR; Heal DJ; Grahame-Smith DG; Kelly PH
    Neuropharmacology; 1976 Oct; 15(10):591-9. PubMed ID: 825788
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
    Laitinen K; Crawley JN; Mefford IN; De Witte P
    Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique effect of remoxipride on dopamine utilization in the basal ganglia.
    Fuxe K; Ogren SO
    Acta Physiol Scand; 1991 Apr; 141(4):577-8. PubMed ID: 1678908
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
    Ervin GN; Nemeroff CB
    Neuropsychopharmacology; 1988 Sep; 1(3):243-50. PubMed ID: 3150806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus.
    Heal DJ; Green AR
    Neuropharmacology; 1979 Jan; 18(1):23-31. PubMed ID: 105304
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between catecholamines and serotonin: relevance to the pharmacology of schizophrenia.
    Svensson TH; Mathé JM; Nomikos GG; Schilström B; Marcus M; Fagerquist M
    Adv Pharmacol; 1998; 42():814-8. PubMed ID: 9328022
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area.
    Kalivas PW; Taylor S
    Brain Res; 1985 Dec; 358(1-2):70-6. PubMed ID: 4075132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-dependent contralateral circling induced by neurotensin applied unilaterally to the ventral tegmental area in rats.
    Holmes LJ; Wise RA
    Brain Res Bull; 1985 Nov; 15(5):537-8. PubMed ID: 4063843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
    Kinkead B; Nemeroff CB
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological correlates of psychomotor stimulant-induced sensitization.
    Henry DJ; White FJ
    Ann N Y Acad Sci; 1992 Jun; 654():88-100. PubMed ID: 1385937
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.